Cat. No.: X25-03-ZQ421
Cisplatin reagent, Cisplatin-PEG-xanthan, Purity ≥95%
Synonym: Cisplatin-xanthan; Xanthan-PEG-Cisplatin
Size
100 mg; 250 mg; 500 mg; 1 g; 5 g; 25 g
| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
| X25-03-ZQ421-1 |
PEG 350 Da |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-2 |
PEG 550 Da |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-3 |
PEG 750 Da |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-4 |
PEG 1 kDa |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-5 |
PEG 2 kDa |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-6 |
PEG 3 kDa |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-7 |
PEG 4 kDa |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-8 |
PEG 5 kDa |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-9 |
PEG 10 kDa |
Xanthan |
Cisplatin |
Inquiry
|
| X25-03-ZQ421-10 |
PEG 20 kDa |
Xanthan |
Cisplatin |
Inquiry
|
Properties
Description
This platinum-based compound conjugate features cisplatin, an anticancer drug, linked to the polysaccharide xanthan via a polyethylene glycol (PEG) spacer, potentially enabling targeted drug delivery or reduced systemic toxicity studies.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
Cisplatin-PEG-xanthan is soluble in a wide range of organic solvents, such as DCM, DMF, and DMSO, and shows excellent solubility in water.
Identity
Confirmed by NMR.
Stability
The product is stable for 1 year when stored at the recommended temperature in powder.
Quality Level
Research grade
Applications
Cisplatin-PEG-xanthan can be used to study the interactions and delivery of this chemotherapy drug in non-therapeutic research models.
Storage
Store at -20°C, protect from light.
For Research Use Only. Not For Clinical Use.